FUJIFILM Diosynth Biotechnologies appoints Maja Pedersen as chief quality officer
Betsy Goodfellow | October 6, 2023 | Appointment | Business Services | Fujifilm, Fujifilm Diosynth Biotechnologies, Maja Pedersen, Pharmacy, appointment, chief quality officer
CEO and president of FUJIFULM Diosynth Biotechnologies Lars Petersen has appointed Maja Pedersen as chief quality officer, where she will serve as a member of the executive leadership team.
Pedersen is a veteran executive with 20 years of leadership experience. She recently worked at Biogen where she served as the global head of External Manufacturing, and prior to that she served as head of quality and qualified person. During this role, Pedersen was responsible for the successful startup of large-scale manufacturing capabilities and securing commercial manufacturing licenses for lifesaving products.
Lars Petersen, president and chief executive officer of FUJFILM Diosynth Biotechnologies, said: “We are pleased to welcome back Maja Pedersen to FUJIFILM Diosynth Biotechnologies to lead our global quality initiatives. She has tremendous experience driving a quality culture with focus on patients and with a firm belief in quality as an enabler which has proven to deliver results in strong quality ownership across functions.”
Maja Pedersen commented: “I am thrilled to be joining FUJIFILM Diosynth Biotechnologies again and becoming an integral part of leading our teams to develop and embed a transformational quality culture. Reliability and quality are cornerstones in the company’s strategic principles, and I am excited to be engaging with our people and our partners on how we ensure unprecedented customer delivery for the benefit of patients.”
James Spargo
Related Content
Johnson & Johnson commits $2bn to new manufacturing facility in North Carolina, US
Johnson & Johnson has announced a $2bn investment in a new manufacturing facility in Holly …
David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.
Fujifilm to invest $2bn in new US cell culture production site
Fujifilm has announced it is investing $2 billion to establish a new large-scale cell culture …
